Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Penumbra, Inc. (NYSE:PEN)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Penumbra, Inc. (NYSE:PEN - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,033 shares of the company's stock, valued at approximately $2,148,000.

Several other hedge funds also recently modified their holdings of PEN. Quadrant Capital Group LLC increased its position in shares of Penumbra by 6.6% during the fourth quarter. Quadrant Capital Group LLC now owns 632 shares of the company's stock valued at $150,000 after purchasing an additional 39 shares during the period. Baker Avenue Asset Management LP increased its position in shares of Penumbra by 1.6% during the fourth quarter. Baker Avenue Asset Management LP now owns 3,330 shares of the company's stock valued at $791,000 after purchasing an additional 53 shares during the period. Fifth Third Bancorp increased its position in shares of Penumbra by 16.4% during the first quarter. Fifth Third Bancorp now owns 404 shares of the company's stock valued at $108,000 after purchasing an additional 57 shares during the period. First Horizon Advisors Inc. increased its position in shares of Penumbra by 404.8% during the first quarter. First Horizon Advisors Inc. now owns 106 shares of the company's stock valued at $28,000 after purchasing an additional 85 shares during the period. Finally, Treasurer of the State of North Carolina increased its position in shares of Penumbra by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 16,213 shares of the company's stock valued at $3,850,000 after purchasing an additional 100 shares during the period. 88.88% of the stock is owned by institutional investors.

Insider Transactions at Penumbra

In other Penumbra news, CEO Adam Elsesser sold 16,650 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $289.37, for a total value of $4,818,010.50. Following the completion of the transaction, the chief executive officer directly owned 75,237 shares in the company, valued at $21,771,330.69. This trade represents a 18.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Johanna Roberts sold 900 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $298.55, for a total value of $268,695.00. Following the completion of the transaction, the executive vice president owned 65,314 shares of the company's stock, valued at approximately $19,499,494.70. This represents a 1.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 115,735 shares of company stock valued at $30,476,510. 4.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on PEN shares. Morgan Stanley upped their price target on Penumbra from $260.00 to $266.00 and gave the company an "equal weight" rating in a research report on Thursday. BTIG Research reaffirmed a "buy" rating on shares of Penumbra in a research note on Thursday, April 24th. Robert W. Baird upped their price target on Penumbra from $283.00 to $285.00 and gave the company an "outperform" rating in a research note on Wednesday. Stifel Nicolaus set a $318.00 price target on Penumbra and gave the company a "buy" rating in a research note on Thursday, April 24th. Finally, Citigroup cut their price target on Penumbra from $320.00 to $285.00 and set a "neutral" rating on the stock in a research note on Wednesday, July 9th. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Penumbra has a consensus rating of "Buy" and an average target price of $300.47.

Penumbra Stock Down 3.9%

Shares of PEN traded down $9.77 during midday trading on Friday, hitting $242.50. The stock had a trading volume of 694,067 shares, compared to its average volume of 496,865. The company has a 50 day simple moving average of $249.95 and a two-hundred day simple moving average of $267.30. Penumbra, Inc. has a twelve month low of $163.63 and a twelve month high of $310.00. The firm has a market cap of $9.46 billion, a price-to-earnings ratio of 71.87, a price-to-earnings-growth ratio of 2.27 and a beta of 0.40. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.75 and a quick ratio of 3.68.

Penumbra (NYSE:PEN - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.05. The business had revenue of $339.46 million during the quarter, compared to the consensus estimate of $327.37 million. Penumbra had a return on equity of 11.55% and a net margin of 11.54%. Penumbra's quarterly revenue was up 13.4% on a year-over-year basis. During the same period last year, the company earned $0.64 earnings per share. On average, analysts anticipate that Penumbra, Inc. will post 3.67 EPS for the current year.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.